142 related articles for article (PubMed ID: 24448776)
1. Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.
Prieto-Alhambra D; Petri H; Goldenberg JS; Khong TP; Klungel OH; Robinson NJ; de Vries F
Osteoporos Int; 2014 Mar; 25(3):847-55. PubMed ID: 24448776
[TBL] [Abstract][Full Text] [Related]
2. Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States.
Khong TP; de Vries F; Goldenberg JS; Klungel OH; Robinson NJ; Ibáñez L; Petri H
Calcif Tissue Int; 2012 Jul; 91(1):24-31. PubMed ID: 22566242
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.
Bakken MS; Engeland A; Engesæter LB; Ranhoff AH; Hunskaar S; Ruths S
Age Ageing; 2013 Jul; 42(4):514-20. PubMed ID: 23438446
[TBL] [Abstract][Full Text] [Related]
4. Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands.
van de Ven LI; Klop C; Overbeek JA; de Vries F; Burden AM; Janssen PK
Osteoporos Int; 2018 Nov; 29(11):2477-2485. PubMed ID: 30112636
[TBL] [Abstract][Full Text] [Related]
5. Forecasting the burden of future postmenopausal hip fractures.
Omsland TK; Magnus JH
Osteoporos Int; 2014 Oct; 25(10):2493-6. PubMed ID: 24980184
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.
Oderda LH; Young JR; Asche CV; Pepper GA
Ann Pharmacother; 2012; 46(7-8):917-28. PubMed ID: 22811347
[TBL] [Abstract][Full Text] [Related]
7. All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.
de Bruin IJA; Klop C; Wyers CE; Overbeek JA; Geusens PPMM; van den Bergh JPW; Driessen JHM; de Vries F
Osteoporos Int; 2019 Mar; 30(3):573-581. PubMed ID: 30737577
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective serotonin reuptake inhibitors and other antidepressant drugs on the risk of hip fracture: a case-control study in an elderly Mediterranean population.
Gorgas MQ; Torres F; Vives R; Lopez-Rico I; Capella D; Pontes C
Eur J Hosp Pharm; 2021 Jan; 28(1):28-32. PubMed ID: 33355280
[TBL] [Abstract][Full Text] [Related]
9. Relationship between use of antidepressants and risk of fractures: a meta-analysis.
Rabenda V; Nicolet D; Beaudart C; Bruyère O; Reginster JY
Osteoporos Int; 2013 Jan; 24(1):121-37. PubMed ID: 22638709
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis.
Hu J; Xie K; Wu S; Chen Y
Actas Esp Psiquiatr; 2024 Jun; 52(3):334-346. PubMed ID: 38863057
[TBL] [Abstract][Full Text] [Related]
11. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Disease and Drugs on Hip Fracture Risk.
Leavy B; Michaëlsson K; Åberg AC; Melhus H; Byberg L
Calcif Tissue Int; 2017 Jan; 100(1):1-12. PubMed ID: 27671989
[TBL] [Abstract][Full Text] [Related]
13. The population attributable risk of nutrition and lifestyle on hip fractures.
Pripp AH; Dahl OE
Hip Int; 2015; 25(3):277-81. PubMed ID: 25907388
[TBL] [Abstract][Full Text] [Related]
14. Association Between Antidepressant Drug Use and Hip Fracture in Older People Before and After Treatment Initiation.
Brännström J; Lövheim H; Gustafson Y; Nordström P
JAMA Psychiatry; 2019 Feb; 76(2):172-179. PubMed ID: 30601883
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.
Arbouw ME; Movig KL; van Staa TP; Egberts AC; Souverein PC; de Vries F
Osteoporos Int; 2011 Jul; 22(7):2197-204. PubMed ID: 20967420
[TBL] [Abstract][Full Text] [Related]
16. Treatment for older men with fractures.
Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy.
Leach MJ; Pratt NL; Roughead EE
Drugs Real World Outcomes; 2017 Dec; 4(4):247-255. PubMed ID: 28940138
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2017 Dec; 32(12):e107-e115. PubMed ID: 28055139
[TBL] [Abstract][Full Text] [Related]
19. Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.
Souverein PC; Abbing-Karahagopian V; Martin E; Huerta C; de Abajo F; Leufkens HG; Candore G; Alvarez Y; Slattery J; Miret M; Requena G; Gil MJ; Groenwold RH; Reynolds R; Schlienger RG; Logie JW; de Groot MC; Klungel OH; van Staa TP; Egberts TC; De Bruin ML; Gardarsdottir H
Pharmacoepidemiol Drug Saf; 2016 Mar; 25 Suppl 1():88-102. PubMed ID: 27038355
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system active medications and risk for fractures in older women.
Ensrud KE; Blackwell T; Mangione CM; Bowman PJ; Bauer DC; Schwartz A; Hanlon JT; Nevitt MC; Whooley MA;
Arch Intern Med; 2003 Apr; 163(8):949-57. PubMed ID: 12719205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
